Search

everythinglearnresearchcommunity

for

Search:↓

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Anti-androgens are not better than birth control pills for PCOS, but can help with excess hair if pills don't work.

Treat hair loss in postmenopausal women with diet, avoiding certain drugs, and using medications like minoxidil or finasteride.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

A woman developed male characteristics after using unregulated hormone therapy.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Antiandrogens don't help with COVID-19 and aren't recommended.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Antiandrogens can help treat female pattern hair loss.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Antiandrogen therapy, like cyproterone acetate, effectively treats acne, hirsutism, and hair loss.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.